Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Nagel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Behavioral and Brain Sciences|November 19, 2021
The distinctive character of knowledgeJennifer Nagel
The Behavioral and Brain Sciences|January 23, 2018
Epistemic authority, episodic memory, and the sense of selfJennifer Nagel
Cognition|February 9, 2021
Mindreading in conversationEvan Westra, Jennifer Nagel
Cognition|September 18, 2013
Authentic Gettier cases: a reply to Starmans and FriedmanJennifer Nagel, Raymond Mar, Valerie San Juan
Cognition|March 16, 2013
Lay denial of knowledge for justified true beliefsJennifer Nagel, Valerie San Juan, Raymond A Mar
Current Medical Research and Opinion|January 6, 2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathologyJacques Touchon, Howard Bergman, Roger Bullock, et al.
The New Phytologist|April 23, 2022
Eco-evolutionary causes and consequences of rarity in plants: a meta-analysisJennifer Nagel Boyd, Jill T Anderson, Jessica Brzyski, et al.
Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.
Ecology and Evolution|September 18, 2023
Phenotypic plasticity and genetic diversity shed light on endemism of rare <i>Boechera perstellata</i> and its potential vulnerability to climate warmingJennifer Nagel Boyd, Carol Baskauf, Annie Lindsay, et al.
Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Behavioral and Brain Sciences|November 19, 2021
The distinctive character of knowledgeJennifer Nagel
The Behavioral and Brain Sciences|January 23, 2018
Epistemic authority, episodic memory, and the sense of selfJennifer Nagel
Cognition|February 9, 2021
Mindreading in conversationEvan Westra, Jennifer Nagel
Cognition|September 18, 2013
Authentic Gettier cases: a reply to Starmans and FriedmanJennifer Nagel, Raymond Mar, Valerie San Juan
Cognition|March 16, 2013
Lay denial of knowledge for justified true beliefsJennifer Nagel, Valerie San Juan, Raymond A Mar
Current Medical Research and Opinion|January 6, 2006
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathologyJacques Touchon, Howard Bergman, Roger Bullock, et al.
The New Phytologist|April 23, 2022
Eco-evolutionary causes and consequences of rarity in plants: a meta-analysisJennifer Nagel Boyd, Jill T Anderson, Jessica Brzyski, et al.
Current Medical Research and Opinion|April 1, 2006
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's diseaseRoger Bullock, Howard Bergman, Jacques Touchon, et al.
Ecology and Evolution|September 18, 2023
Phenotypic plasticity and genetic diversity shed light on endemism of rare <i>Boechera perstellata</i> and its potential vulnerability to climate warmingJennifer Nagel Boyd, Carol Baskauf, Annie Lindsay, et al.
Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.
Pageof 2